XML 26 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Nov. 28, 2016
OPERATING ACTIVITIES          
Net loss $ (5,111) $ (6,002) $ (7,589) $ (9,663)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation 49 15 21 10  
Interest and revaluation of convertible notes, net 237      
Interest and amortization of discount on convertible notes     237 333  
Share-based transaction costs incurred in reverse recapitalization     7,258  
Financing loss on debt extinguishment 2,364 2,364  
Changes in fair value of derivative warrant liability (23) (274) (285) (262)  
Shares issued as consideration-vendor 74      
Share-based compensation expense 1,139 176 479 676  
Changes in assets and liabilities:          
Other receivables (32) 29 (14) 538  
Other payables and accrued liabilities 29 (92) (69) 324  
Net cash used in operating activities (3,875) (3,547) (4,856) (786)  
INVESTMENT ACTIVITIES          
Increase in restricted cash (27)  
Purchase of property and equipment (239) (28) (58) (25)  
Net cash used in investing activities (239) (28) (85) (25)  
FINANCING ACTIVITIES          
Acquisition of a subsidiary in connection with reverse recapitalization     269  
Transaction costs incurred in reverse recapitalization     (347)  
Outflow (inflow) in connection with current assets and liabilities acquired in reverse recapitalization, net (82) 317 2,002  
Exercise of warrants issued upon conversion of notes     409  
Issuance of common stock, net of issuance costs 12,704 12,702  
Issuance of convertible notes     750  
Net cash provided by financing activities 12,622 13,019 3,083  
Net increase (decrease) in cash and cash equivalents and restricted cash (4,114) 9,047 8,078 2,272  
Cash and cash equivalents and restricted cash at the beginning of the period 10,814 2,709 2,709 437  
Cash and cash equivalents and restricted cash at the end of the period 6,700 11,756 10,814 2,709  
Non-cash financing transactions:          
Cashless exercise of warrants [1] [1]  
Conversion of preferred A shares into common shares [1] [1] 90  
Extinguishment of convertible notes in exchange for preferred A shares $ 2,083 $ 2,083  
Assets acquired (liabilities assumed):          
Current assets excluding cash and cash equivalents         $ (3,618)
Current liabilities         811
Derivative warrant liability         575
Convertible note         2,029
Reverse recapitalization effect on equity         472
Cash acquired in connection with reverse recapitalization         $ 269
[1] Less than 1